FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149926390> ?p ?o ?g. }

• W2149926390 endingPage "F29" @default.
• W2149926390 startingPage "F28" @default.
• W2149926390 abstract "EDITORIAL FOCUSDiabetic nephropathy: nitric oxide and renal medullary hypoxiaJennifer S. Pollock, and Pamela K. CarminesJennifer S. Pollock, and Pamela K. CarminesPublished Online:01 Jan 2008https://doi.org/10.1152/ajprenal.00525.2007This is the final version - click for previous versionMoreSectionsPDF (43 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat diabetes, specifically diabetic nephropathy, is the most frequent cause of end-stage renal disease (ESRD) in developed countries (10). Classically, studies into the mechanisms underlying diabetic nephropathy have focused on glomerular injury and the development of albuminuria; however, changes in tubulointerstitial structure and function are also evident even during the early stages in diabetes (3, 4, 11, 13, 14, 16). Changes in proximal tubule structure consistent with hypertrophy (increases in cell height, tubule diameter, and length) are a prominent component of diabetic renal hypertrophy, with other nephron segments also displaying changes in tubule length (13, 14). There is evidence of altered renal handling of electrolytes, including Na+, and increased renal Na+-K+-ATPase (NKA) activity has been widely reported in diabetes. The changes in NKA activity accompanying type 1 diabetes mellitus coincide with, and thus may play a role in, the development of hypertrophy. On the other hand, as NKA-mediated ion transport is the major consumer of metabolic energy in the kidney, the early and pronounced increase in tubular NKA activity in diabetes has been proposed to represent an important adaptive response to the osmotic diuresis (4, 16) and/or the chronic increase in filtered Na+ load. Upregulation of NKA activity is particularly evident in the outer medulla (3, 4, 16), where low blood flow limits O2 supply despite high O2 consumption coupled with reabsorptive Na+ transport. As O2 extraction is almost maximal under normal conditions in the outer medulla, the increased NKA activity linked to increased Na+ transport during diabetes is accompanied by reduced Po2 in this region that normally exists near the brink of hypoxia. Thus diabetes would promote chronic hypoxia, which may be a common pathway leading to ESRD (8).In the healthy kidney, the renal medulla has high concentrations of nitric oxide (NO) (18). Reduced NO bioavailability has been shown to result in increased O2 consumption and, therefore, increased sodium reabsorption in the renal medulla (2, 5). Diabetes is known to be a condition of oxidative stress and reduced NO bioavailability. Little information is available in the literature pertaining to the status of NO and O2 availability in the renal medulla during diabetes. Palm and colleagues (12) have begun to unravel the complex mechanisms involved in the interrelationship between reduced NO bioavailability and hypoxia in the renal medulla in the early stages of diabetes. Palm et al. (12) report that reduced renal medullary NO levels in diabetes are due to decreased plasma l-arginine and unrelated to diabetes-induced oxidative stress, while the reduction in medullary Po2 was restored by l-arginine administration or antioxidant treatment. The authors also observed that the O2 availability in both normal and diabetic rats was independent of blood flow alterations. These observations underscore the potential importance of diabetes-induced renal metabolic alterations and their functional consequences.At physiological concentrations, NO inhibits the mitochondrial enzyme cytochrome c oxidase (complex IV) in competition with O2, thereby impeding mitochondrial respiration (17). When NO levels are decreased, such as in diabetes, this regulatory mechanism is dysfunctional, thus allowing increased mitochondrial respiration and O2 consumption. Thus, in addition to effects of diabetes to increase Na+ transport-dependent O2 consumption and NKA activity in the outer medulla, altered NO bioavailability may increase mitochondrial O2 consumption and contribute to reduced Po2 under these conditions. Although the validity of this scenario remains speculative, the data from Palm et al. (12) establish a link between NO synthase substrate availability and the changes in medullary Po2 accompanying diabetes.Hypoxia induces regulatory mechanisms via its influence on gene expression, specifically through a family of transcription factors known as hypoxia inducible factors (HIFs). HIFs are considered to be master regulators of gene expression during hypoxia, impacting expression of almost all glycolytic enzymes and glucose transporters (15). HIF expression is inversely related to Po2 in multiple cell types, including cells of the renal medulla (19). Renal HIF levels are low or absent under normal conditions, with hypoxia provoking HIF accumulation that varies with respect to isoform, kidney zone, cell type, and the exact nature of the hypoxic stimulus (15, 19). Most HIF-induced responses confer protection against hypoxic injury; however, renal profibrotic genes have also been shown to be directly upregulated by hypoxia (7, 9). NO has been shown to regulate the activity and/or expression of HIF-degrading enzymes with no clear consensus on whether NO activates or blunts the HIF-degrading enzymatic activity (1, 6). Very little information is available concerning whether HIF activates renoprotective mechanisms and profibrotic genes in the hypoxia-prone renal medulla during diabetes and/or whether NO regulates HIF levels under these conditions.The observations of Palm et al. (12) should fuel future studies that focus on the interaction of NO and O2 availability, as well as the effects of NO on mitochondrial respiration and HIF-dependent responses, during the early stages of diabetes in the renal medulla. These processes associated with renal medullary hypoxia may interact in an additive or synergistic manner with the hemodynamic events that evoke glomerular hyperfiltration, ultimately contributing to the development of diabetic nephropathy.REFERENCES1 Berchner-Pfannschmidt U, Yamac H, Trinidad B, Fandrey J. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem 282: 1788–1796, 2007.Crossref | PubMed | ISI | Google Scholar2 Deng A, Miracle CM, Suarez JM, Lortie M, Satriano J, Thomson SC, Munger KA, Blantz RC. Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II. Kidney Int 68: 723–730, 2005.Crossref | PubMed | ISI | Google Scholar3 Ku DD, Meezan E. Increased renal tubular sodium pump and Na+,K+-adenosine triphosphatase in streptozotocin-diabetic rats. J Pharmacol Exp Ther 229: 664–670, 1984.PubMed | ISI | Google Scholar4 Ku DD, Sellers BM, Meezan E. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats. Endocrinology 119: 672–679, 1986.Crossref | PubMed | ISI | Google Scholar5 Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjletti A, Hintze TH. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 82: 1263–1271, 1998.Crossref | PubMed | ISI | Google Scholar6 Li N, Yi F, Sundy CM, Chen L, Hilliker ML, Donley DK, Muldoon DB, Li PL. Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. Am J Physiol Renal Physiol 292: F207–F216, 2007.PubMed | ISI | Google Scholar7 Maxwell P. HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol 14: 2712–2722, 2003.Crossref | PubMed | ISI | Google Scholar8 Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17–25, 2006.Crossref | PubMed | ISI | Google Scholar9 Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58: 2351–2366, 2000.Crossref | PubMed | ISI | Google Scholar10 O'Connor AS, Schelling JR. Diabetes and the kidney. Am J Kidney Dis 46: 766–773, 2005.Crossref | PubMed | ISI | Google Scholar11 Palm F, Hansell P, Ronquist G, Waldenstrom A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 47: 1223–1231, 2004.Crossref | PubMed | ISI | Google Scholar12 Palm F, Friederich M, Carlsson P-O, Hansell P, Teerlink T, Liss P. Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability. Am J Physiol Renal Physiol. doi:10.1152/ajprenal.00166.2007.Google Scholar13 Rasch R. Tubular lesions in streptozotocin diabetic rats. Diabetologia 27: 32–37, 1984.Crossref | PubMed | ISI | Google Scholar14 Rasch R, Torffvit O, Bachmann S, Jensen PK, Jacobsen NO. Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion. Diabetologia 38: 525–535, 1995.Crossref | PubMed | ISI | Google Scholar15 Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU. Expression of hypoxia-inducible factor-1 alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13: 1721–1732, 2002.Crossref | PubMed | ISI | Google Scholar16 Wald H, Scherzer P, Popovtzer MM. Enhanced renal tubular ouabain-sensitive ATPase in streptozotocin diabetes mellitus. Am J Physiol Renal Fluid Electrolyte Physiol 251: F164–F170, 1986.Link | ISI | Google Scholar17 Xu W, Charles IG, Moncada S. Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response. Cell Res 15: 63–65, 2005.Crossref | PubMed | ISI | Google Scholar18 Zou AP, Cowley AW Jr. Nitric oxide in renal cortex and medulla. An in vivo microdialysis study. Hypertension 29: 194–198, 1997.Crossref | PubMed | ISI | Google Scholar19 Zou AP, Yang ZZ, Li PL, Cowley AW Jr. Oxygen-dependent expression of hypoxia-inducible factor 1 alpha in renal medullary cells of rats. Physiol Genomics 6: 159–168, 2001.Link | ISI | Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: J. S. Pollock, Vascular Biology Center, CB 3213, 1459 Laney Walker Blvd., Medical College of Georgia, Augusta, GA 30912 (e-mail: [email protected]) Download PDF Previous Back to Top Next FiguresReferencesRelatedInformationCited ByNoninvasive Evaluation of Renal Hypoxia by Multiparametric Functional MRI in Early Diabetic Kidney Disease28 June 2021 | Journal of Magnetic Resonance Imaging, Vol. 55, No. 2Sensitivity and specificity of ischaemia-modified albumin in detecting diabetic nephropathyThe Egyptian Journal of Internal Medicine, Vol. 30, No. 4Effects of iodinated contrast agents on renal oxygenation level determined by blood oxygenation level dependent magnetic resonance imaging in rabbit models of type 1 and type 2 diabetic nephropathy2 September 2014 | BMC Nephrology, Vol. 15, No. 1Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidneyKidney International, Vol. 85, No. 3Renal Cortical and Medullary MicrocirculationsHyperglycemia Causes Renal Cell Damage via CCN2-Induced Activation of the TrkA Receptor17 August 2012 | Diabetes, Vol. 61, No. 9Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRIEuropean Journal of Radiology, Vol. 81, No. 7Higher hemoglobin level is associated with subtle declines in renal function and presence of cardiorenal risk factors in early CKD stages9 June 2011 | Nephrology Dialysis Transplantation, Vol. 27, No. 1The Low Number of Red Blood Cells Is an Important Risk Factor for All-Cause Mortality in the General PopulationThe Tohoku Journal of Experimental Medicine, Vol. 227, No. 2Contrast-enhanced ultrasonography with Sonazoid for evaluation of renal microcirculation16 December 2008 | Journal of Medical Ultrasonics, Vol. 35, No. 4 More from this issue > Volume 294Issue 1January 2008Pages F28-F29 Copyright & PermissionsCopyright © 2008 the American Physiological Societyhttps://doi.org/10.1152/ajprenal.00525.2007PubMed18003855History Published online 1 January 2008 Published in print 1 January 2008 Metrics" @default.
• W2149926390 created "2016-06-24" @default.
• W2149926390 creator A5003642259 @default.
• W2149926390 creator A5018254950 @default.
• W2149926390 date "2008-01-01" @default.
• W2149926390 modified "2023-09-27" @default.
• W2149926390 title "Diabetic nephropathy: nitric oxide and renal medullary hypoxia" @default.
• W2149926390 cites W1976589215 @default.
• W2149926390 cites W1985703856 @default.
• W2149926390 cites W1989847367 @default.
• W2149926390 cites W2046990824 @default.
• W2149926390 cites W2053711278 @default.
• W2149926390 cites W2085943887 @default.
• W2149926390 cites W2092122589 @default.
• W2149926390 cites W2095529051 @default.
• W2149926390 cites W2126714905 @default.
• W2149926390 cites W2135705997 @default.
• W2149926390 cites W2140704005 @default.
• W2149926390 cites W2144447642 @default.
• W2149926390 cites W2152183809 @default.
• W2149926390 cites W2158458517 @default.
• W2149926390 cites W2159746300 @default.
• W2149926390 cites W2164945237 @default.
• W2149926390 cites W2233427033 @default.
• W2149926390 cites W2470359562 @default.
• W2149926390 cites W2582837188 @default.
• W2149926390 doi "https://doi.org/10.1152/ajprenal.00525.2007" @default.
• W2149926390 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18003855" @default.
• W2149926390 hasPublicationYear "2008" @default.
• W2149926390 type Work @default.
• W2149926390 sameAs 2149926390 @default.
• W2149926390 citedByCount "15" @default.
• W2149926390 countsByYear W21499263902012 @default.
• W2149926390 countsByYear W21499263902013 @default.
• W2149926390 countsByYear W21499263902014 @default.
• W2149926390 countsByYear W21499263902018 @default.
• W2149926390 countsByYear W21499263902021 @default.
• W2149926390 crossrefType "journal-article" @default.
• W2149926390 hasAuthorship W2149926390A5003642259 @default.
• W2149926390 hasAuthorship W2149926390A5018254950 @default.
• W2149926390 hasConcept C126322002 @default.
• W2149926390 hasConcept C126894567 @default.
• W2149926390 hasConcept C134018914 @default.
• W2149926390 hasConcept C164705383 @default.
• W2149926390 hasConcept C178790620 @default.
• W2149926390 hasConcept C185592680 @default.
• W2149926390 hasConcept C195121873 @default.
• W2149926390 hasConcept C2779922275 @default.
• W2149926390 hasConcept C2780091579 @default.
• W2149926390 hasConcept C2781184683 @default.
• W2149926390 hasConcept C519581460 @default.
• W2149926390 hasConcept C540031477 @default.
• W2149926390 hasConcept C555293320 @default.
• W2149926390 hasConcept C71924100 @default.
• W2149926390 hasConcept C7836513 @default.
• W2149926390 hasConceptScore W2149926390C126322002 @default.
• W2149926390 hasConceptScore W2149926390C126894567 @default.
• W2149926390 hasConceptScore W2149926390C134018914 @default.
• W2149926390 hasConceptScore W2149926390C164705383 @default.
• W2149926390 hasConceptScore W2149926390C178790620 @default.
• W2149926390 hasConceptScore W2149926390C185592680 @default.
• W2149926390 hasConceptScore W2149926390C195121873 @default.
• W2149926390 hasConceptScore W2149926390C2779922275 @default.
• W2149926390 hasConceptScore W2149926390C2780091579 @default.
• W2149926390 hasConceptScore W2149926390C2781184683 @default.
• W2149926390 hasConceptScore W2149926390C519581460 @default.
• W2149926390 hasConceptScore W2149926390C540031477 @default.
• W2149926390 hasConceptScore W2149926390C555293320 @default.
• W2149926390 hasConceptScore W2149926390C71924100 @default.
• W2149926390 hasConceptScore W2149926390C7836513 @default.
• W2149926390 hasIssue "1" @default.
• W2149926390 hasLocation W21499263901 @default.
• W2149926390 hasLocation W21499263902 @default.
• W2149926390 hasOpenAccess W2149926390 @default.
• W2149926390 hasPrimaryLocation W21499263901 @default.
• W2149926390 hasRelatedWork W1978258537 @default.
• W2149926390 hasRelatedWork W2013701055 @default.
• W2149926390 hasRelatedWork W2186283074 @default.
• W2149926390 hasRelatedWork W2356203034 @default.
• W2149926390 hasRelatedWork W2364308849 @default.
• W2149926390 hasRelatedWork W2381954214 @default.
• W2149926390 hasRelatedWork W2382058954 @default.
• W2149926390 hasRelatedWork W2392413698 @default.
• W2149926390 hasRelatedWork W2439321369 @default.
• W2149926390 hasRelatedWork W3186246677 @default.
• W2149926390 hasVolume "294" @default.
• W2149926390 isParatext "false" @default.
• W2149926390 isRetracted "false" @default.
• W2149926390 magId "2149926390" @default.
• W2149926390 workType "article" @default.